A retrospective study on immune-related pneumonitis in patients with non-small-cell lung cancer undergoing treatment with PD-1/PD-L1 inhibitors

BACKGROUND: Lung cancer patients undergoing treatment with immune checkpoint inhibitors (ICIs) are at risk of developing immune-related (ir-)pneumonitis. Since lung cancer patients have competing reasons for respiratory symptoms, this poses a diagnostic challenge. This study aimed to explore diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakymenko, Dorthe, Skougaard, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071953/
https://www.ncbi.nlm.nih.gov/pubmed/37025977
http://dx.doi.org/10.1080/20018525.2023.2194162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071953/
https://www.ncbi.nlm.nih.gov/pubmed/37025977
http://dx.doi.org/10.1080/20018525.2023.2194162

Ejemplares similares